Hypertension is relatively uncommon in children and few children receive antihypertensive medications. This article reviews the safety of calcium channel blockers, angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in children with hypertension. While the newer antihypertensive agents appear to be well-tolerated by children, further studies are needed to determine the safety profile across the developmental continuum, with chronic dosing and in children with complex hypertension.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1517/14740338.1.1.39 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative Effectiveness of Lercanidipine and Amlodipine on Major Adverse Cardiovascular Events in Hypertensive Patients.
Am J Hypertens
January 2025
Division of Cardiology, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Republic of Korea.
Background: Lercanidipine, a newer-generation calcium channel blocker, is recognized for its effective antihypertensive properties and reduced side effects. This study aims to compare the effectiveness of lercanidipine and amlodipine in preventing major adverse cardiovascular events (MACE) in hypertensive patients.
Methods: A multicenter, retrospective observational study was conducted using the electronic medical records database from 3 tertiary hospitals in South Korea between 2017 and 2021.
Pulmonary arterial hypertension: updates and perspective with newer therapies.
Intern Med J
December 2024
Department of Respiratory Medicine, Alfred Hospital, Melbourne, Victoria, Australia.
Pulmonary arterial hypertension (PAH) is a rare condition for which a remarkable change has been witnessed in the epidemiology, assessment and treatment landscape over the last three decades. Well-established registries from the Western world have not only highlighted the shift in the epidemiology to an older, more comorbid cohort but have also identified markers of prognosis that have been validated as part of risk stratification scores in multiple cohorts. The emphasis on early identification through a systematic assessment pathway and the option of upfront combination therapy with serial risk stratification assessment has laid the foundation for the standard of care and improved prognosis.
View Article and Find Full Text PDFUnveiling novel molecules and therapeutic targets in hypertension - A narrative review.
Eur J Pharmacol
December 2024
MP Shah Medical College, Gujarat, India.
Article Synopsis
- * Current treatments mainly focus on the renin-angiotensin-aldosterone system but often provide limited success, leading some patients to develop treatment-resistant hypertension.
- * New therapies are emerging that target different aspects of hypertension, including the nervous system and inflammation, but they face significant challenges that could affect their effectiveness and acceptability in long-term use.
Blood pressure targets, medication consideration and special concerns in elderly hypertension part I: General principles and special considerations.
J Formos Med Assoc
September 2024
Division of Cardiology, Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Hsinchu City, Taiwan. Electronic address:
To achieve a consensus on optimal blood pressure (BP) targets for older adults remains challenging, necessitating a trade-off between cardiovascular benefits and the risk of impaired organ perfusion. Evidence suggests that age and frailty have a minimal influence on the cardiovascular benefits of intensive BP control in community-dwelling elderly. Nonetheless, an increased incidence of acute kidney injury with intensive BP control has been observed in octogenarians.
View Article and Find Full Text PDFBlood Pressure Management Strategies and Podocyte Health.
Am J Hypertens
January 2025
Division of Nephrology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA.
Hypertension (HTN) is one of the key global cardiovascular risk factors, which is tightly linked to kidney health and disease development. Podocytes, glomerular epithelial cells that play a pivotal role in maintenance of the renal filtration barrier, are significantly affected by increased glomerular capillary pressure in HTN. Damage or loss of these cells causes proteinuria, which marks the initiation of the HTN-driven renal damage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!